HMGCR and cancer: A commonly employed approach for inferring causal effects of statins on cancer in an MR context is to utilise genetic variants in the gene encoding the drug target of statins, HMGCR, that are robustly associated with LDL cholesterol levels as proxies for pharmacological inhibition of this drug target.